Lupus & antiphospholipid syndrome

Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort

LupusPublished Inception cohort study

Main finding · Damage accrualResult — go to the resultHazard ratio 1.09 95% CI 0.93–1.28

Authors' conclusion

In this inception cohort, a maximum time of 24 months with a median of 6 months to SLE diagnosis had no apparent negative impact on disease outcomes (damage accrual and mortality).

Study context

Population
Patients with systemic lupus erythematosus (SLE) from a multi-ethnic, multinational Latin American inception cohort; centres with specialized lupus clinics
Participants
1,437 patients
Exposure
Time to diagnosis >6 months vs shorter time to diagnosis
  • Longer time to diagnosisn = 721
Outcome
Damage accrual and mortality
Methodological detailsmulti-ethnic, multinational, multivariable Cox regression
  • Multi-ethnic
  • Multinational
  • Multivariable Cox regression

Main finding

Damage accrual

Hazard ratio

1.09

95% CI 0.93–1.28

P = 0.300

Longer time to diagnosisvs Shorter time to diagnosis
HR 1.09 (95% CI 0.93–1.28); P = 0.300

As reported in the abstract

Observational data: associations, not effects.

Further findings

Characteristics associated with time to diagnosis >6 months

More frequently female, older at diagnosis, of Mestizo ethnicity, without medical insurance, and with "non-classic" SLE symptoms

Time to SLE diagnosis

Median time to diagnosis, months (Q1-Q3 2.4-16.2)
6.0
Time to diagnosis longer than 6 months, n (%)
721 (50.2%)

Original publication

Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort. Lupus. Published 9 February 2024. doi:10.1177/09612033241232821

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.